Invitae Co. (NYSE:NVTA – Get Rating) insider Robert L. Nussbaum sold 26,476 shares of the company’s stock in a transaction on Tuesday, May 16th. The shares were sold at an average price of $1.20, for a total value of $31,771.20. Following the completion of the sale, the insider now owns 576,431 shares of the company’s […]
Invitae Co. (NYSE:NVTA – Get Rating) CFO Yafei Wen sold 43,452 shares of Invitae stock in a transaction dated Tuesday, May 16th. The stock was sold at an average price of $1.99, for a total value of $86,469.48. Following the transaction, the chief financial officer now directly owns 700,297 shares in the company, valued at […]
Invitae Co. (NYSE:NVTA – Get Rating) has been assigned a consensus recommendation of “Hold” from the twelve brokerages that are currently covering the firm, MarketBeat reports. Five equities research analysts have rated the stock with a sell rating and five have given a hold rating to the company. The average 12-month target price among brokers […]
Invitae Co. (NYSE:NVTA – Get Rating) – Equities research analysts at SVB Leerink raised their Q2 2023 earnings per share (EPS) estimates for shares of Invitae in a note issued to investors on Tuesday, May 9th. SVB Leerink analyst P. Souda now anticipates that the medical research company will post earnings per share of ($0.34) […]
Shares of Invitae Co. (NYSE:NVTA – Get Rating) have been assigned an average rating of “Hold” from the twelve research firms that are currently covering the stock, MarketBeat Ratings reports. Five research analysts have rated the stock with a sell rating and six have assigned a hold rating to the company. The average 1-year price […]